NO975634L - Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater - Google Patents
Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparaterInfo
- Publication number
- NO975634L NO975634L NO975634A NO975634A NO975634L NO 975634 L NO975634 L NO 975634L NO 975634 A NO975634 A NO 975634A NO 975634 A NO975634 A NO 975634A NO 975634 L NO975634 L NO 975634L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- tiludronate
- preparation
- hydrates
- stable
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- -1 tiludronate hydrates Chemical class 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 229940019375 tiludronate Drugs 0.000 title 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3865—Polyphosphonic acids containing sulfur substituents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/488,986 US5656288A (en) | 1995-06-08 | 1995-06-08 | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| PCT/US1996/008790 WO1996041618A1 (en) | 1995-06-08 | 1996-06-04 | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975634D0 NO975634D0 (no) | 1997-12-04 |
| NO975634L true NO975634L (no) | 1998-01-29 |
Family
ID=23941935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975634A NO975634L (no) | 1995-06-08 | 1997-12-04 | Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5656288A (es) |
| EP (1) | EP0831789A1 (es) |
| JP (1) | JPH11507924A (es) |
| AR (1) | AR003434A1 (es) |
| AU (1) | AU5980896A (es) |
| BR (1) | BR9609477A (es) |
| CA (1) | CA2223568A1 (es) |
| MX (1) | MX9709838A (es) |
| NO (1) | NO975634L (es) |
| WO (1) | WO1996041618A1 (es) |
| ZA (1) | ZA964752B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
| EP1378234A1 (en) * | 1996-05-17 | 2004-01-07 | MERCK & CO. INC. | Effervescent bisphosphonate formulation |
| DE69726879T2 (de) * | 1996-05-17 | 2004-10-14 | Merck & Co., Inc. | Biphosphonat-formulierung mit brausewirkung |
| EP0998933A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| US6410520B2 (en) * | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| US7488496B2 (en) | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
| US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
| WO2005023805A1 (en) * | 2003-09-04 | 2005-03-17 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| JP2007505886A (ja) * | 2003-09-19 | 2007-03-15 | ファイザー・プロダクツ・インク | ２−メチレン−１９−ノル−ビタミンｄ誘導体及びビスホスフォネートの組み合わせを含む医薬組成物及び方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694558B1 (fr) * | 1992-08-05 | 1994-10-28 | Sanofi Elf | Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant. |
-
1995
- 1995-06-08 US US08/488,986 patent/US5656288A/en not_active Expired - Fee Related
-
1996
- 1996-06-04 CA CA002223568A patent/CA2223568A1/en not_active Abandoned
- 1996-06-04 JP JP9503130A patent/JPH11507924A/ja not_active Withdrawn
- 1996-06-04 BR BR9609477A patent/BR9609477A/pt not_active Application Discontinuation
- 1996-06-04 EP EP96917140A patent/EP0831789A1/en not_active Withdrawn
- 1996-06-04 WO PCT/US1996/008790 patent/WO1996041618A1/en not_active Application Discontinuation
- 1996-06-04 AU AU59808/96A patent/AU5980896A/en not_active Abandoned
- 1996-06-06 ZA ZA964752A patent/ZA964752B/xx unknown
- 1996-06-11 AR ARP960103106A patent/AR003434A1/es unknown
-
1997
- 1997-12-04 NO NO975634A patent/NO975634L/no unknown
- 1997-12-08 MX MX9709838A patent/MX9709838A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0831789A1 (en) | 1998-04-01 |
| WO1996041618A1 (en) | 1996-12-27 |
| CA2223568A1 (en) | 1996-12-27 |
| ZA964752B (en) | 1997-01-13 |
| BR9609477A (pt) | 1999-05-25 |
| US5656288A (en) | 1997-08-12 |
| MX9709838A (es) | 1998-08-30 |
| NO975634D0 (no) | 1997-12-04 |
| JPH11507924A (ja) | 1999-07-13 |
| AU5980896A (en) | 1997-01-09 |
| AR003434A1 (es) | 1998-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY128809A (en) | Pharmaceutical formulation of omeprazole | |
| UA63993C2 (uk) | Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул | |
| IS1694B (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| PL341055A1 (en) | Novel form of a drug for oral administration of active compounds being unstable in acid environments | |
| GEP20033014B (en) | Enteric Coated Pharmaceutical Composition and Method of Manufacturing | |
| AU6136199A (en) | Dosage form comprising therapeutic formulation | |
| IS3957A (is) | Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun | |
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| PT1126828E (pt) | Administração oral de análogos de adenosina | |
| NO974404D0 (no) | Insufflasjonsbærer for medikamenter med kontrollert frigivelse | |
| IS5526A (is) | 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum | |
| MY127350A (en) | Flash-melt oral dose formulations | |
| NO975634L (no) | Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater | |
| MXPA04003346A (es) | Formulacion de dosis oral de disolucion instantanea. | |
| GB9814215D0 (en) | Anti-inflammatory pharmaceutical formulations | |
| IS4030A (is) | Lyf, ætlað til inntöku, sem hefur bakteríueyðandiáhrif í maga, aðferð við framleiðslu þess og notkun | |
| ATE192435T1 (de) | Verbindungen mit analgetischem und lokalanesthetischem effekt | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| NO180450C (no) | Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin | |
| EE9600050A (et) | Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks | |
| JO1821B1 (en) | New pharmaceutical product | |
| JO1880B1 (en) | Format 1 for multi-unit calibration discs | |
| NO964775L (no) | Fast farmasöytisk adenosinholdig preparat | |
| YU28404A (sh) | Brzo topljiva formulacija za oralno doziranje | |
| UA39418A (uk) | Спосіб лікування виразкової хвороби, асоційованої з helicobacter pylori |